8-K: Nexalin Technology Faces Nasdaq Delisting

Nexalin Technology, Inc. has received a delisting notice from Nasdaq due to failure to meet minimum bid price and stockholders equity requirements, with an appeal pending.

Summary

• Nexalin Technology, Inc. has been notified by Nasdaq that its common stock will be delisted from The Nasdaq Capital Market.
• The company failed to regain compliance with the Minimum Bid Price Requirement (closing below $1.00 for 30 consecutive business days).
• Nasdaq also cited the company's non-compliance with the $5,000,000 minimum stockholders equity initial listing requirement.
• Securities will be suspended at the opening of business on August 4, 2026, with a Form 25-NSE to be filed.
• The company has requested a hearing before a Nasdaq Hearings Panel to appeal the determination.
• A hearing request will stay the suspension and delisting process pending the Panel's decision.
• The company may need to present a plan to regain compliance, potentially including a reverse stock split.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the imminent delisting from Nasdaq, indicating significant financial distress and a high degree of uncertainty regarding the company's future on a major exchange.

Positives

• The company has timely requested a hearing before the Nasdaq Hearings Panel to appeal the delisting determination.
• A hearing request will stay the suspension of the company's securities and the filing of the Form 25-NSE pending the Panel's decision.

Negatives

• The company has not regained compliance with Nasdaq's Minimum Bid Price Requirement.
• The company does not comply with the $5,000,000 minimum stockholders equity initial listing requirement for The Nasdaq Capital Market.
• Nasdaq has determined that the company's securities will be scheduled for delisting.
• Securities will be suspended at the opening of business on August 4, 2026.
• A Form 25-NSE will be filed to remove the company's securities from listing and registration on The Nasdaq Stock Market.

Risks

• Failure to regain compliance with Nasdaq listing requirements could lead to continued delisting.
• There is no assurance that the Nasdaq Hearings Panel will grant the company's request for continued listing.
• The company may not be able to regain compliance with applicable Nasdaq listing requirements.
• Potential need to effect a reverse stock split to regain compliance.

Future Outlook

The company is appealing Nasdaq's delisting determination and has requested a hearing. The outcome of this appeal is uncertain, and there is no guarantee of continued listing or the ability to regain compliance with Nasdaq's requirements. A reverse stock split may be considered as part of a compliance plan.

Management Comments

• The Company has timely requested a hearing before the Panel to appeal Nasdaqs determination.
• There can be no assurance that the Panel will grant the Companys request for continued listing or that the Company will be able to regain compliance with the applicable Nasdaq listing requirements.
• The Company will be asked to provide a plan to regain compliance to the Panel, which may include a discussion of the events the Company believes will enable it to regain compliance and a commitment to effect a reverse stock split, if necessary.

Industry Context

StockSavvy.ai notes that Nasdaq delisting actions are typically triggered by sustained underperformance in share price or failure to meet financial health metrics, signaling significant challenges for the company's market standing and investor confidence.

Stakeholder Impact

• Shareholders: Potential loss of liquidity and market access if delisted from Nasdaq, which could negatively impact share value.
• Creditors: Increased risk due to the company's financial standing and potential delisting.
• Employees: Uncertainty regarding job security and company stability.

Next Steps

• Attend hearing before the Nasdaq Hearings Panel.
• Present a plan to regain compliance to the Panel.
• Potentially effect a reverse stock split if required.
• Await the Panel's decision on continued listing.

Key Dates

Recommendation

Given the pending appeal and the possibility of a reverse stock split, a 'hold' recommendation is appropriate. Investors should await the outcome of the Nasdaq Hearings Panel decision before making further investment decisions. The company's ability to regain compliance is uncertain, but the appeal process offers a potential path forward.

Keywords

Nasdaq Delisting, Minimum Bid Price, Stockholders Equity, Listing Requirements, Securities Suspension, Form 25-NSE, Nasdaq Hearings Panel, Compliance Plan